COMMUNIQUÉS West-GlobeNewswire

-
NKGen Biotech Provides Clarification on Quotation Display and Trading Status on the OTC Expert Market
09/10/2025 -
Consortium consisting of Nordic Capital and Permira receives final regulatory approval in respect of its takeover offer to the shareholders of Bavarian Nordic
09/10/2025 -
RenovoRx Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD
09/10/2025 -
CytoDyn to Present at the LD Micro Main Event XIX Investor Conference
09/10/2025 -
Iolyx Therapeutics Announces Upcoming Presentation at Eyecelerator 2025 and Poster at the American Academy of Ophthalmology Annual Meeting
09/10/2025 -
Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution
09/10/2025 -
Digital Utilities Ventures Completes Acquisition and Name Change
09/10/2025 -
Akari Therapeutics Files Two New Patents for Immuno-Oncology Mode of Action for Novel ADC Platform Utilizing Spliceosome Modulating Payload PH1
09/10/2025 -
Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology
09/10/2025 -
Journal of Clinical Microbiology Studies Demonstrate Two Investigational Diagnostics Outperform Current Tests in Detecting Early Lyme Disease
09/10/2025 -
Doheny Eye Institute Announces Upcoming Presentations at the American Academy of Ophthalmology 2025 Annual Meeting
09/10/2025 -
Safety Shot, Inc. to Become Bonk, Inc., to Trade on Nasdaq Under New Ticker Symbol “BNKK”
09/10/2025 -
Children's National Hospital receives $8 million grant from Gilbert Family Foundation to advance neurofibromatosis research
09/10/2025 -
Legend Senior Living® Grows Florida Footprint With Renaissance of North Tampa
09/10/2025 -
Foundation Health Secures $20M Series A to Scale AI-Powered Infrastructure for Pharmacy Operations, Care Coordination, and Direct-to-Patient Delivery
09/10/2025 -
Triumph Steps Launches CLE-Eligible Mental Fitness Program for Lawyers
09/10/2025 -
Optime Care Terminates Distributor Agreement for Korlym® (mifepristone)
09/10/2025 -
Toro Neurovascular and Kaneka Announce Exclusive U.S. Distribution Partnership
09/10/2025 -
Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer
09/10/2025
Pages